Excientia PLC (Nasdaq: EXAI), relating to its proposed merger with Recursion Pharmaceuticals, Inc. Under the terms of the agreement, each share of Exscientia common stock will be automatically converted into the right to receive 0.7729 shares of Recursion common stock.